ranolazine has been researched along with vernakalant in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| DiMarco, JP; Mason, PK | 1 |
| Dobrev, D; Nattel, S | 1 |
| Brachmann, J; Ritscher, G; Simon Demel, K; Simon, H; Turschner, O | 1 |
| Antzelevitch, C; Gibson, JK; Lynch, JJ; Pourrier, M; Sicouri, S | 1 |
| Franz, MR; Singh, SN | 1 |
| Antzelevitch, C; Burashnikov, A; Gibson, JK; Lynch, JJ; Pourrier, M | 1 |
| Saklani, P; Skanes, A | 1 |
| Ravens, U | 1 |
| Clauss, C; Eckardt, L; Frommeyer, G; Grotthoff, JS; Grundmann, F; Kaese, S; Milberg, P; Pott, C; Ramtin, S; Schmidt, M | 1 |
| Capucci, A; Guerra, F; Matassini, MV; Scappini, L; Urbinati, A | 1 |
| Bögeholz, N; Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Güner, F; Kochhäuser, S; Leitz, P; Pott, C | 1 |
| Bögeholz, N; Dechering, DG; Eckardt, L; Fehr, M; Frommeyer, G; Kochhäuser, S; Sterneberg, M | 1 |
| Bove, T; Cilenti, F; Copetti, R; Cristiani, L; Guglielmo, N; Orso, D; Santangelo, S | 1 |
7 review(s) available for ranolazine and vernakalant
| Article | Year |
|---|---|
New pharmacological agents for arrhythmias.
Topics: Acetanilides; Adenosine A1 Receptor Agonists; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzazepines; Benzofurans; Clinical Trials as Topic; Dronedarone; Humans; Ivabradine; Piperazines; Pyrrolidines; Ranolazine | 2009 |
New antiarrhythmic drugs for treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Atrial Fibrillation; Dronedarone; Humans; Piperazines; Pyrrolidines; Ranolazine; Renin-Angiotensin System | 2010 |
[New developments in the antiarrhythmic therapy of atrial fibrillation].
Topics: Acetanilides; Aged; Amiodarone; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Drug-Related Side Effects and Adverse Reactions; Drugs, Investigational; Electrocardiography; Heart Atria; Heart Failure; Heart Ventricles; Humans; Piperazines; Potassium Channels; Pyrrolidines; Ranolazine; Sodium Channels; Stroke | 2010 |
Novel anti-arrhythmic medications in the treatment of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Digoxin; Dronedarone; Forecasting; Heart Failure; Humans; Phenethylamines; Piperazines; Pyrrolidines; Ranolazine; Sulfonamides; Technology, Pharmaceutical; Ventricular Dysfunction, Left | 2012 |
[New developments in the antiarrhythmic therapy of atrial fibrillation].
Topics: Acetanilides; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dose-Response Relationship, Drug; Dronedarone; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Piperazines; Pyrrolidines; Ranolazine; Sodium Channel Blockers; Treatment Outcome | 2014 |
New anthyarrhythmic drugs for atrial fibrillation.
Topics: Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Dronedarone; Humans; Pyrrolidines; Ranolazine | 2015 |
Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Network Meta-Analysis; Quinidine; Randomized Controlled Trials as Topic; Ranolazine; Systematic Reviews as Topic; Verapamil | 2023 |
6 other study(ies) available for ranolazine and vernakalant
| Article | Year |
|---|---|
Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.
Topics: Acetanilides; Action Potentials; Adrenergic beta-Agonists; Animals; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; Cardiac Electrophysiology; Cell Membrane; Dogs; Heart Rate; Humans; Isoproterenol; Membrane Potentials; Piperazines; Pulmonary Veins; Pyrrolidines; Ranolazine; Sodium Channels; Sotalol | 2012 |
Comparative pharmacophysiology of vernakalant, ranolazine, and d-sotalol in canine pulmonary vein sleeve preparations: new flavors or same old taste?
Topics: Acetanilides; Animals; Anisoles; Atrial Fibrillation; Humans; Piperazines; Pulmonary Veins; Pyrrolidines; Ranolazine; Sodium Channels; Sotalol | 2012 |
Rate-dependent effects of vernakalant in the isolated non-remodeled canine left atria are primarily due to block of the sodium channel: comparison with ranolazine and dl-sotalol.
Topics: Acetanilides; Action Potentials; Animals; Anisoles; Anti-Arrhythmia Agents; Dogs; Female; Heart Atria; In Vitro Techniques; Male; Models, Animal; Piperazines; Pyrrolidines; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sodium Channels; Sotalol; Time Factors | 2012 |
Electrophysiological profile of vernakalant in an experimental whole-heart model: the absence of proarrhythmia despite significant effect on myocardial repolarization.
Topics: Acetanilides; Action Potentials; Animals; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiologic Techniques, Cardiac; Heart Conduction System; In Vitro Techniques; Models, Animal; Perfusion; Piperazines; Potassium Channel Blockers; Pyrrolidines; Rabbits; Ranolazine; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sotalol; Time Factors | 2014 |
Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.
Topics: Action Potentials; Animals; Anisoles; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Disease Models, Animal; Electrocardiography; Heart Rate; Isolated Heart Preparation; Pinacidil; Pyrrolidines; Rabbits; Ranolazine; Sodium Channel Blockers; Time Factors; Ventricular Fibrillation | 2016 |
Comparison of vernakalant and ranolazine in atrial fibrillation.
Topics: Animals; Anisoles; Atrial Fibrillation; Cardiovascular Agents; Drug Evaluation, Preclinical; In Vitro Techniques; Pyrrolidines; Rabbits; Ranolazine | 2017 |